PRMT5 and its substrate-binding partner MEP50 (encoded by WDR77) were substantially upregulated in ibrutinib-resistant MCL cells (Fig. 3a, b) along with that of PRMT1 and PRMT7 (Supplementary Fig. S2a, b). Here, PRMT5 is linked to mantle cell lymphoma.